Literature DB >> 16502316

The prognostic value of circulating plasma DNA level and its allelic imbalance on chromosome 8p in patients with hepatocellular carcinoma.

Ning Ren1, Lun-Xiu Qin, Hong Tu, Yin-Kun Liu, Bo-Heng Zhang, Zhao-You Tang.   

Abstract

PURPOSE: We demonstrated that chromosome 8p deletion is associated with metastasis of human hepatocellular carcinoma (HCC). This study assesses the value of circulating plasma DNA level and its allelic imbalance (AI) on chromosome 8p in the prediction of HCC prognosis.
METHODS: Blood samples were collected from 79 patients with HCC before operation, 20 patients with liver cirrhosis, and 20 healthy volunteers. The HCC and adjacent non-tumor liver tissues were obtained from surgical specimens. Plasma DNA was extracted and quantified. Two microsatellite markers on chromosome 8p, D8S258 and D8S264, were selected and used in the AI analysis.
RESULTS: The circulating plasma DNA level was found to closely associate with tumor size (P=0.008) and TNM stage (P=0.040), negatively associate with the 3-year disease-free survival (DFS) (P=0.017) and overall survival (OS) (P=0.001). AI at D8S258 in plasma DNA was significantly correlated with tumor differentiation (P=0.050), TNM stage (P=0.010), and vascular invasion (P=0.023), negatively correlated with the 3-year DFS (P=0.005) and OS (P=0.036). However, AI at D8S264 was only closely associated with 3-year DFS (P=0.014). Combined detection of AI at D8S258 and circulating plasma DNA level was independently associated with DFS (P=0.018) and OS (P=0.002) of patients with HCC. For patients with both AI at D8S258 and a higher level of plasma DNA, the 3-year DFS and 3-year OS rates were decreased remarkably (P=0.014 and 0.044).
CONCLUSION: Combination of circulating plasma DNA level and AI at D8S258 might be an independent predictor for prognosis of HCC patients.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16502316     DOI: 10.1007/s00432-005-0049-5

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  57 in total

1.  Localization of tumor suppressor gene associated with distant metastasis of urinary bladder cancer to a 1-Mb interval on 8p22.

Authors:  K Ohgaki; A Iida; O Ogawa; Y Kubota; M Akimoto; M Emi
Journal:  Genes Chromosomes Cancer       Date:  1999-05       Impact factor: 5.006

2.  [Not Available].

Authors:  P MANDEL; P METAIS
Journal:  C R Seances Soc Biol Fil       Date:  1948-02

3.  Microsatellite analysis of free tumor DNA in urine, serum, and plasma of patients: a minimally invasive method for the detection of bladder cancer.

Authors:  Michael Utting; Wolfram Werner; Regine Dahse; Jörg Schubert; Kerstin Junker
Journal:  Clin Cancer Res       Date:  2002-01       Impact factor: 12.531

4.  Functional evidence for a metastasis suppressor gene for rat prostate cancer within a 60-kilobase region on human chromosome 8p21-p12.

Authors:  Naoki Nihei; Natalya Kouprina; Vladimir Larionov; Junko Oshima; George M Martin; Tomohiko Ichikawa; J Carl Barrett
Journal:  Cancer Res       Date:  2002-01-15       Impact factor: 12.701

5.  Detection of epithelial tumour RNA in the plasma of colon cancer patients is associated with advanced stages and circulating tumour cells.

Authors:  J M Silva; R Rodriguez; J M Garcia; C Muñoz; J Silva; G Dominguez; M Provencio; P España; F Bonilla
Journal:  Gut       Date:  2002-04       Impact factor: 23.059

6.  Evaluation of the clonal relationship between primary and metastatic renal cell carcinoma by comparative genomic hybridization.

Authors:  H Bissig; J Richter; R Desper; V Meier; P Schraml; A A Schäffer; G Sauter; M J Mihatsch; H Moch
Journal:  Am J Pathol       Date:  1999-07       Impact factor: 4.307

7.  Recurrent DNA copy number losses associated with metastasis of larynx carcinoma.

Authors:  M Kujawski; M Sarlomo-Rikala; A Gabriel; K Szyfter; S Knuutila
Journal:  Genes Chromosomes Cancer       Date:  1999-11       Impact factor: 5.006

8.  The association of chromosome 8p deletion and tumor metastasis in human hepatocellular carcinoma.

Authors:  L X Qin; Z Y Tang; J S Sham; Z C Ma; S L Ye; X D Zhou; Z Q Wu; J M Trent; X Y Guan
Journal:  Cancer Res       Date:  1999-11-15       Impact factor: 12.701

9.  Chromosome 8 Losses in Colorectal Carcinoma: Localization and Correlation With Invasive Disease.

Authors: 
Journal:  Mol Diagn       Date:  1997-03

10.  Cytogenetic analyses of secondary liver tumors reveal significant differences in genomic imbalances between primary and metastatic colon carcinomas.

Authors:  L A Parada; A Marañon; M Hallén; K G Tranberg; U Stenram; G Bardi; B Johansson
Journal:  Clin Exp Metastasis       Date:  1999       Impact factor: 5.150

View more
  32 in total

1.  Quantitation of plasma circulating DNA using quantitative PCR for the detection of hepatocellular carcinoma.

Authors:  Zhaohui Huang; Dong Hua; Yu Hu; Zhihong Cheng; Xike Zhou; Qigen Xie; Qiongyao Wang; Feng Wang; Xiang Du; Yanjun Zeng
Journal:  Pathol Oncol Res       Date:  2011-07-21       Impact factor: 3.201

Review 2.  The clinical role of 'liquid biopsy' in hepatocellular carcinoma.

Authors:  Jessica A Howell; Rohini Sharma
Journal:  Hepat Oncol       Date:  2015-11-30

Review 3.  Cell-free nucleic acids as biomarkers in cancer patients.

Authors:  Heidi Schwarzenbach; Dave S B Hoon; Klaus Pantel
Journal:  Nat Rev Cancer       Date:  2011-05-12       Impact factor: 60.716

4.  Post-treatment cell-free DNA as a predictive biomarker in molecular-targeted therapy of hepatocellular carcinoma.

Authors:  Takuma Nakatsuka; Hayato Nakagawa; Yuki Hayata; Taijiro Wake; Tomoharu Yamada; Mizuki Nishibatake Kinoshita; Ryo Nakagomi; Masaya Sato; Tatsuya Minami; Koji Uchino; Kenichiro Enooku; Yotaro Kudo; Yasuo Tanaka; Takahiro Kishikawa; Motoyuki Otsuka; Ryosuke Tateishi; Kazuhiko Koike
Journal:  J Gastroenterol       Date:  2021-03-12       Impact factor: 7.527

Review 5.  Liquid Biopsy and its Potential for Management of Hepatocellular Carcinoma.

Authors:  Jian Zhou; Ao Huang; Xin-Rong Yang
Journal:  J Gastrointest Cancer       Date:  2016-06

6.  The value of liquid biopsy in the diagnosis and staging of hepatocellular carcinoma: a systematic review.

Authors:  Poh Tan; Lisa Grundy; Peter Makary; Khem Hua Eng; George Ramsay; Mohamed Bekheit
Journal:  Transl Gastroenterol Hepatol       Date:  2021-10-25

Review 7.  Utility of Liquid Biopsy Analysis in Detection of Hepatocellular Carcinoma, Determination of Prognosis, and Disease Monitoring: A Systematic Review.

Authors:  Vincent L Chen; Dabo Xu; Max S Wicha; Anna S Lok; Neehar D Parikh
Journal:  Clin Gastroenterol Hepatol       Date:  2020-04-11       Impact factor: 11.382

8.  Value of circulating cell-free DNA in diagnosis of hepatocelluar carcinoma.

Authors:  Ken Chen; Hong Zhang; Li-Na Zhang; Shao-Qing Ju; Jing Qi; Dong-Feng Huang; Feng Li; Qun Wei; Jing Zhang
Journal:  World J Gastroenterol       Date:  2013-05-28       Impact factor: 5.742

9.  A cluster of cooperating tumor-suppressor gene candidates in chromosomal deletions.

Authors:  Wen Xue; Thomas Kitzing; Stephanie Roessler; Johannes Zuber; Alexander Krasnitz; Nikolaus Schultz; Kate Revill; Susann Weissmueller; Amy R Rappaport; Janelle Simon; Jack Zhang; Weijun Luo; James Hicks; Lars Zender; Xin Wei Wang; Scott Powers; Michael Wigler; Scott W Lowe
Journal:  Proc Natl Acad Sci U S A       Date:  2012-05-07       Impact factor: 11.205

Review 10.  Liquid Biopsy in Hepatocellular Carcinoma: Where Are We Now?

Authors:  Filippo Pelizzaro; Romilda Cardin; Barbara Penzo; Elisa Pinto; Alessandro Vitale; Umberto Cillo; Francesco Paolo Russo; Fabio Farinati
Journal:  Cancers (Basel)       Date:  2021-05-10       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.